Top Story

Platelet transfusions associated with increased risk for death in HIT, TTP

January 27, 2015

Platelet transfusions are frequently used in patients with thrombotic thrombocytopenic purpura, immune thrombocytopenic purpura and heparin-induced thrombocytopenia, according to study results.

However, use of platelet transfusions in patients with thrombotic thrombocytopenic purpura (TTP) and heparin-induced thrombocytopenia (HIT) was associated with an increased risk for arterial thrombosis and mortality, results showed.

In the Journals

CRC incidence increasing in young adults

January 27, 2015
The incidence of colorectal cancer is increasing among the young adult population while decreasing among adults in the screened population, according to new research…
In the Journals

Targeted fusion-guided biopsy improved detection of high-risk prostate cancers

January 27, 2015
Targeted magnetic resonance/ultrasound fusion prostate biopsy detected significantly more cases of high-risk prostate cancers than standard extended-sextant biopsy in…
Meeting News Coverage

Pembrolizumab appears safe, effective in advanced gastric cancer

January 27, 2015
The novel agent pembrolizumab demonstrated promising antitumor activity and manageable toxicity in patients with advanced gastric cancer, according to study results…
Kim F. Rhoads, MD In the Journals

Integrated health care may eliminate racial disparities in colon cancer survival

January 26, 2015
Providing fair, high-quality, evidence-based care can eliminate racial disparities in survival outcomes among patients with colon cancer, according to results of a…
More News Headlines »
CME CNE
High Risk AAMDS

Treatment Decision-Making through the Spectrum of MDS:
Case 2 High Risk MDS

An educational presentation from Aplastic Anemia & MDS International Foundation.

MDS is a difficult disease to diagnose and treat. Frequently it is challenging for healthcare providers to explain to…
More »
Meeting News Coverage Video
Genome editing demonstrated wide application for blood disorders

Genome editing demonstrated wide application for blood disorders

January 4, 2015
SAN FRANCISCO — Ralph Green, MD, PhD, FRCPath, medical director of the UC Davis Health System Medical…
More »
CME
Hot melanoma

Targeted Therapy and Immunotherapy in the Management of Metastatic Melanoma: 2014 Updates - Monograph

Melanoma remains a challenging condition for clinicians. An array of targeted therapies and immunotherapy are in…
More »